The 61st ASH Annual Meeting: Unwrapping the Best From Hematology's Christmas
2019 ASH News Daily Editor Dr. Ayesha Zia recaps the 61st ASH Annual Meeting and Exposition which took place early December in Orlando.
Act Fast! Making a Difference After Traumatic Brain Injury With Tranexamic Acid
Dr. Tseng discusses several studies that investigate the efficacy and safety of tranexamic acid in patients with traumatic brain injury.
Expert opinion focused on challenging diagnostic and management issues
Drs. Gaurav Goyal and Ronald Go discuss the diagnosis and management of Erdheim-Chester disease.
Dr. Anne Neff outlines a rational approach to distinguishing between immune thrombocytopenia purpura and inherited thrombocytopenia.
Drs. Chancellor Donald and Cindy Leissinger discuss their approach to acquired thrombotic thrombocytopenic purpura (TTP) with multiple relapses.
Dr. Daniel Lenihan discusses whether ibrutinib therapy can increase the risk of serious rhythm disturbances.
Dr. Gary Lyman examines the safety and efficacy of biosimilars approved by the U.S. Food and Drug Administration.
Dr. Kahn provides advice on recruiting and inspiring residents to subspecialize and become hematologists.
Dr. D'Souza provides insight into her approach to the diagnosis and management of monoclonal gammopathy of renal significance (MGRS).
Drs. Pemmaraju and Konopleva share their expertise treating blastic plasmacytoid dendritic cell neoplasm.
Dr. Sweet presents the case of a 48-year-old woman with chronic-phase chronic myeloid leukemia being treated effectively with imatinib, and contemplates whether the patient is a candidate for a trial of tyrosine kinase inhibitor cessation.
Dr. Lazarus and Dr. Ljungman discuss the optimal approach to prevent cytomegalovirus infection in patients undergoing allogeneic hematopoietic cell transplantation in 2018.
January-February 2020Volume 17, Issue 1
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology